Olympus Corp
OLY1
Company Profile
Business description
Olympus is a medical-device maker with a leading position in the endoscope market and a diversified global revenue stream. Originally founded in 1919 in Japan as a microscope and camera maker, Olympus has gradually pivoted into endoscopic and therapeutic solutions. As of March 2025, more than 60% of its revenue comes from endoscopic solutions. In addition, North America is the biggest revenue contributor by region, accounting for 38% of its total revenue.
Contact
2951 Ishikawacho
Hachioji192-8507
JPNT: +81 333402111
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 March 2026
Employees
29,996
Stocks News & Analysis
stocks
Our three most overvalued ASX shares
These three companies are trading at a significant premium to our fair value.
stocks
What does big US court decision mean for Google’s parent company Alphabet?
Alphabet shares popped 7% after the ruling on September 2 and have now rallied by around 50% since April.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,111.80 | 17.60 | -0.19% |
| CAC 40 | 7,656.10 | 42.82 | -0.56% |
| DAX 40 | 23,625.66 | 144.67 | -0.61% |
| Dow JONES (US) | 45,316.53 | 304.76 | -0.67% |
| FTSE 100 | 9,204.98 | 11.89 | -0.13% |
| HKSE | 25,480.03 | 62.05 | 0.24% |
| NASDAQ | 21,621.71 | 85.98 | -0.40% |
| Nikkei 225 | 43,814.14 | 795.39 | 1.85% |
| NZX 50 Index | 13,242.85 | 19.32 | 0.15% |
| S&P 500 | 6,464.58 | 37.50 | -0.58% |
| S&P/ASX 200 | 8,838.60 | 16.60 | -0.19% |
| SSE Composite Index | 3,821.02 | 8.51 | 0.22% |